Ishihara, H., Takagi, T., Kondo, T., Tachibana, H., Yoshida, K., Omae, K., … Tanabe, K. (2018). Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-018-1241-3 (Original work published 2018)

Fuke, N., Takagi, T., Higashimura, Y., Tsuji, T., Umeda, R., Mizushima, K., … Naito, Y. (2018). Lactobacillus brevis KB290 With Vitamin A Ameliorates Murine Intestinal Inflammation Associated With the Increase of CD11c+ Macrophage/CD103- Dendritic Cell Ratio. Inflammatory Bowel Diseases, 24(2), 317-331. https://doi.org/10.1093/ibd/izx003 (Original work published 2018)

Takagi, T., Naito, Y., Inoue, R., Kashiwagi, S., Uchiyama, K., Mizushima, K., … Itoh, Y. (2018). The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study. Journal of Clinical Biochemistry and Nutrition, 62(1), 100-105. https://doi.org/10.3164/jcbn.17-78